Post-approval studies (Phase 4)Not Yet RecruitingNCT07717736
What this trial is testing
Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds
Who this might be right for
Epidermolysis Bullosa (EB)Recessive Dystrophic Epidermolysis Bullosa (RDEB)Dystrophic Epidermolysis Bullosa (DEB)
Abeona Therapeutics, Inc 100